Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.

Objective: Intranasal esketamine has been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior. The authors conducted a systematic review and meta-analysis of the available data on its efficacy against depression and suicidalit...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Psychiatry Vol. 182; no. 3; pp. 259 - 276
Autores principales: Fountoulakis, Konstantinos N., Saitis, Athanasios, Schatzberg, Alan F.
Formato: Artículo
Publicado: American Psychiatric Publishing, Inc. Mar2025
Materias:
Acceso en línea:Ver este registro en EBSCOhost